Tobacco and Alcohol Research

The Economics of Smoking in Pregnancy (ESIP) Model

ESIP is a dynamic decision analytic model which estimates the impact of ‘within-pregnancy’ smoking cessation interventions on the health costs and benefits for mother and her offspring. It consists of a series of linked models: two decision trees which estimate ‘within-pregnancy’ consequences and then three Markov cohort models which estimate lifetime consequences. A simplified model diagram can be found below.

model diagram

 

About ESIP

Who can use ESIP?
 
How was ESIP constructed and what does it include?
 
What output can ESIP generate?
 

 

Why use ESIP?

ESIP has some key advantages over previously-developed models:

  • A link that allows maternal smoking to directly impact on infant’s health and their smoking uptake.
  • A time horizon which includes all sufficiently impactful short and long-term morbidities and outcomes for both mother and infant.
  • Includes a robust approach to identifying morbidities for inclusion.
  • Allows for greater uncertainty in model parameters than previous models.

Can I see ESIP myself?

Download an Excel file which demonstrates a deterministic analysis conducted in ESIP. Some inputs can be changed (e.g. quit rates, intervention costs), however most parameters cannot.

If you are unsure whether ESIP is suitable for you, you may want to download this Excel file to investigate the estimates ESIP can generate.

*You may download and view this file for your personal non-commercial use, subject to Copyright and the Terms and Conditions below.

How can I use ESIP?

For UK researchers
 
For international researchers
 

 

Pubications using ESIP

About

ESIP has been developed by academics from the Division of Primary Care at the University of Nottingham, the UK Centre for Tobacco & Alcohol Studies, the Universities of Lincoln and York. The project lead is Dr Matthew Jones.

Links

Health Economics Research at Nottingham (Her@N)

Smoking in Pregnancy Research Group

 

Contact 

For further information please contact:

Dr Matthew Jones.

Email: matthew.jones3@nottingham.ac.uk

 

 

 

  

This paper/article/abstract presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Reference Number RP-PG-0109-10020). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. ESIP was also supported by the UK Centre for Tobacco and Alcohol Studies, which receives core funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical
Research Council, and the Department of Health under the auspices of the UK Clinical Research Collaboration.

UKCTAS-350NIHR NHS_Logo_Funded by Stamp-350

 

 

 

Tobacco and Alcohol research

The University of Nottingham

email:Chris Hill